Request Sample

Global Recombinant DNA Technology Market

Dec. 1, 2019

Global Recombinant DNA Technology Market, By Product Type (Recombinant Protein Drugs (Insulin, Human Growth Hormone, Erythropoietin, Interferon, Blood Factors, Colony Stimulating Factors, Fusion Proteins, and Others), Vaccines, Genetically Modified Crops, Expression Systems (Prokaryotic Cells, Mammalian Cells, Yeats, Insect, and Others), Cell and Gene Therapy and Gene Editing), By Application (Therapeutics, Agriculture, and Research), By Region (North America, Latin America, Europe, Asia-Pacific, and Middle East and Africa) - Global Forecast, 2020-2025.

Report Code : FMR297      
Industry : Biotechnology
Pages : 190 Pages
Format :   PPT Format   PDF Format

The global recombinant DNA technology market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). The significantly increased burden of chronic diseases is driving the market growth. For instance, according to National Center for Biotechnology Information (NCBI), the total burden of affected people from cardiovascular and cancer totaled more than 500 million, globally. Additionally, the growing need to boost the processing ability of recombinant proteins and the existence of a comprehensive biopharmaceutical pipeline may support the market growth. Moreover, pharmaceutical companies’ investments on trials for drug candidates, are the leading to the need for successful therapies for treating diseases.

Table 1. Global Recombinant DNA Technology Market Synopsis

Parameters

Description

Market Value (US$ Mn) for the Period

2018-2025

Base Year

2019

Forecast Period

2020-2025

Market Segmentation (By Product Type)

Recombinant Protein Drugs (Insulin, Human Growth Hormone, Erythropoietin, Interferon, Blood Factors, Colony Stimulating Factors, Fusion Proteins, and Others), Vaccines, Genetically Modified Crops, Expression Systems (Prokaryotic Cells, Mammalian Cells, Yeats, Insect, and Others), Cell and Gene Therapy and Gene Editing

Market Segmentation (By Application)

Therapeutics, Agriculture, and Research

Regions Covered

North America, Latin America, Europe, Asia-Pacific, Middle East & Africa,

Key Players Coverage

F. Hoffmann-La Roche Ltd, Biogen, Monsanto Company, Amgen Inc, Novartis AG. Eli Lilly and Company, Pfizer Inc, Genscript, Merck KGaA, Novo Nordisk A/S and among others

Key Insights

  • Latest Updates
  • Analyst Views
  • Future Outlook of the Market

Market Dynamics

The growing need to boost the processing ability of recombinant proteins and the development of a comprehensive biopharmaceutical pipeline indeed is expected to increase the demand for efficient therapies for the treatment of diseases. The biomedical and pharmaceutical industries are trying to incorporate rDNA strategies in various areas of disease control.

 It is primarily for battling the increasing pressure of chronic diseases and keeping up with the rising demand for therapies. However, lack of knowledge of genetic diseases and disorders, traditional healthcare practices, weak healthcare and research infrastructure in various regions of Middle East and Africa, and limited product and service availability are some of the factors which may hamper the growth of the recombinant DNA technology market to some extent.

Figure 1. Recombinant DNA Technology Market Scenario Forecast (Likely, Conservative, and Optimistic Scenario), 2019 and 2025 (US$ Mn)

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

 

The North America contributes a significant share in the recombinant DNA technology market owing to the widespread successful applications of this technique in the development of veterinary products, genetically engineered plants, in the production of biopesticides and biofuels, and gene therapy. All these factors are expected to stimulate the adoption of this technology over the forecast period. The emergence of low-cost drug manufacturing centers in Asian economies, such as China, has brought considerable attention to key players to translocate their manufacturing industry which may support the recombinant DNA technology market growth. For instance, in May 2020, MGI Tech closed a US$ 1 billion series B round backed by IDG Capital and Citic Private Equity Funds to combat the spread of coronavirus. In addition, Japan is recognized as one of the largest per capita importers worldwide of food and animal feed produced using modern biotechnology techniques. Japan's GE crops regulatory system keeps on improving. These procedures are carried out  by making changes in its DNA, which in turn boost the market growth.

Figure 2. Regional Analysis

 

Note: Above figure shown for illustrative purpose only, the actual data may vary and will be incorporated in the report.

Competitve Landscape

Key players in global recombinant DNA technology market include F. Hoffmann-La Roche Ltd, Biogen, Monsanto Company, Amgen Inc, Boehringer Ingelheim, Novartis AG. Eli Lilly and Company, Pfizer Inc, Genscript, Merck KGaA, Novo Nordisk A/S, among others. Key players in the market are engaged in collaborative alliances to offer their services in various life science domain. Moreover, entities are continuously expanding their manufacturing facilities as a viable strategy to stay competitive in the market space.  For instance, in April 2020, Sanofi and GlaxoSmithKline signed a letter of intent to develop an adjuvanted vaccine against the disease, caused by the SARS-CoV-2 virus, using rDNA technology. The companies plan to potentially make the vaccine available in the second quarter of 2021.   

FIgure 3. Market Share of Key Players, 2019

 

Note: Above figure shown for illustrative purpose only, the actual data may vary and will be incorporated in the report.

By Product Type

  • Recombinant Protein Drugs
    • Insulin
    • Human Growth Hormone
    • Erythropoietin
    • Interferon
    • Blood Factors
    • Colony Stimulating Factors
    • Fusion Proteins
    • Others
  • Vaccines
  • Genetically Modified Crops
  • Expression Systems
    • Prokaryotic Cells
    • Mammalian Cells
    • Yeats
    • Insect
    • Others
  • Cell and Gene Therapy
  • Gene Editing

By Application

  • Therapeutics
  • Agriculture
  • Research

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa
rm
Kindly fill the below form and we will contact you within 24 hours
I have read and accept Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Note: This report provides in-depth analysis of the global recombinant DNA technology market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year.

  • What are the trends adopted by key players in the global recombinant DNA technology market?
  • What key factors are expected to increase the demand for recombinant DNA technology market during the forecast period 2020-2025?
  • What are the major challenges inhibiting the growth of the global recombinant DNA technology market?
  • What is the total market value (US$ Mn) generated in global recombinant DNA technology market by product type in 2019 and what are the forecasts by 2025?
  • Which application is expected to dominate the recombinant DNA technology market in the coming years?
  • Which end user is expected to foster the recombinant DNA technology market growth?
  • What was the total revenue generated by the global recombinant DNA technology market across different regions (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) in 2019, along with CAGR (%) for the period (2020-2025)?
  • Who are the key players contributing to the growth of the global recombinant DNA technology market, and what are the new strategies adopted by them to retain a market share in the industry?
  • What is the competitive strength of the key players in the recombinant DNA technology market?
  • What new products are going to be approved or launched in the coming years which may have huge impact on the market?
  • What insights are derived through the analysis of key players on following parameters: company overview, financial performance, product portfolio, geographical presence, key highlights, and strategies?
Latest Reports

Global Recombinant DNA Technology Market

Global Recombinant DNA Technology Market, By Product Type (Recombinant Protein Drugs (Insulin, Human Growth Hormone, Erythropoietin, Interferon, Blood Factors, …

Read More

Global Inactivated Vaccine Market

Global Inactivated Vaccine Market, By Product Type (Viral, Bacterial), By Inactivation method (Radiation Method, pH Concentration, Heat Inactivation, Solvent …

Read More

Middle East and Africa Epigenetics Market

Middle East and Africa Epigenetics Market, By Product type (Consumables, Enzymes, Kits & Reagents, and Instruments), By Application (Oncology, …

Read More

Global Tissue Plasminogen Activator (TPA) Market

Global Tissue Plasminogen Activator (TPA) Market, By Dosage (2mg, 50mg, and 100mg), By Administration Route (Intravenous and Regional Intra-Arterial), …

Read More

Global Biobanks Market

Global Biobanks Market, By Biological samples (DNA or RNA, Plasma, Tissue samples, Stem cells, Amniotic fluid, Cerebrospinal fluid, Blood, …

Read More

Global Vector Control Market

Global Vector Control Market, By Product Type (Insects, Rodents, and Others), Methods of control (Chemical Methods (Pyrethroids (Permethrin, Deltamethrin, …

Read More

Global Medical Drone Market

Global Medical Drone Market, By Type (Fixed Wing, Rotary Drone, and Hybrid Drones), By Application (Search and Rescue (Disaster, …

Read More

Global Agricultural Biotechnological Market

Global Agricultural Biotechnological Market, By Product Type (Plants (Conventional Techniques, Established Genetic Modification, New Breeding Techniques), Animals (Conventional Techniques, …

Read More
Validation error occured. Please enter the fields and submit it again.